Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

OnabotulinumtoxinA significantly reduces urinary incontinence (UI) and improves bladder management in patients with neurogenic detrusor overactivity (NDO). We evaluated the impact of onabotulinumtoxinA on patient-reported outcomes (PROs) in patients with UI due to NDO in a double-blind, placebo-controlled study.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Neurourol. Urodyn.

Title: Neurourology and urodynamics

ISSN (Electronic): 1520-6777

ISSN (Print): 0733-2467

Publication date (Electronic): Mar 2013

Volume: 32

Issue: 3

Affiliations

[1 ] University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine, Division of Urology, Stratford, New Jersey 08084, USA. dosuss@comcast.net

Article

DOI: 10.1002/nau.22293

PubMed ID: 22965657

SO-VID: 48fbfb86-029b-4d32-af41-6b6426541e4f

History

Data availability:

Comments

Comment on this article

scite_

Cited by 15

See all cited by